Analysts’ Viewpoint on Gastrointestinal Testing Panels Market in Europe and Middle East & Africa
Companies in the gastrointestinal testing panels market should accelerate their product development and unlock revenue opportunities to obtain competitive benefits. Market stakeholders are extending their services to gain competitive edge in the healthcare sector. Increasing incidences of gastrointestinal disorders in Europe and Middle East & Africa, along with rapidly increasing elderly population is driving the demand for gastrointestinal testing panels. Moreover, the increasing number of market contributors in EMEA in the gastrointestinal testing panels market are marking their presence and generate lucrative revenue opportunities. Stringent regulations and little knowledge and awareness about the advanced molecular diagnostic methods are factors hampering the growth of the EMEA gastrointestinal testing panels market. In addition, increasing research & development activities in advanced gastrointestinal infection detection methods is fueling the demand for such testing panels, which, in turn, is propelling the growth of the market.
With significant impact on the global economy and businesses, the coronavirus pandemic has put intense pressure on the healthcare system of Europe and Middle East & Africa. The gastrointestinal testing panels market in Europe and Middle East & Africa is affected due to insufficient supply of healthcare equipment, shortage of hospital beds, medical staff, etc. However, gastrointestinal testing panels market is booming after the significant efforts taken by healthcare practitioner and market stakeholders to manage the disrupted supply chain. The increasing demand for gastrointestinal testing panels due to rising incidences of gastrointestinal complications in Europe and Middle East & Africa, along with increasing geriatric population drives market growth. Gastrointestinal complications are caused by bacteria, viruses, and parasites, affecting both stomach and small intestine. The gastrointestinal testing panels gives fast and accurate results for analysis of gastrointestinal infection. The Europe and Middle East & Africa gastrointestinal testing panels market is expected to witness steady growth after the coronavirus breakdown, owing to increasing awareness about health.
The rising prevalence of gastrointestinal disorders in Europe and Middle East & Africa is a major driving factor for the Europe and Middle East & Africa gastrointestinal testing panels market. Unhealthy food habits, hectic lifestyle, disrupted sleep cycle, and excessive stress are some of the key factors responsible for rising incidences of gastrointestinal disorders in Europe and Middle East & Africa. Lack of proper healthcare facilities and unhygienic behavior in some of the emerging countries are the leading causes for increasing cases of diarrheal diseases. Along with diarrhea, abdominal pain and vomiting are the symptoms observed in patients.
The surging growth in patient pool is expected to increase the demand for better gastrointestinal testing panels in Europe and Middle East & Africa. According to the severity of these symptoms, doctors treat the patients using correct diagnosis and proper treatment with the help of gastrointestinal testing panels.
Gastrointestinal testing panel is specifically designed to detect, analyze, and study the gastrointestinal infection using advanced molecular techniques. Viruses, bacteria, and pathogens can be detected using these techniques. Increasing mortality rates due to diarrhea in adults as well as in children is driving the demand for gastrointestinal testing panels in EMEA. Manufacturers in the gastrointestinal testing panels market are targeting on high quality product development due to rising demand and increasing revenue streams. Innovative strategies adopted by healthcare manufacturers to increase the production of gastrointestinal testing devices fuels the market growth.
The rising geriatric population in Europe and Middle East & Africa is one of the major contributing factors for the growth of the gastrointestinal testing panels market. In Europe and Middle East & Africa, there is a rapid growth in gastrointestinal complications in elderly (people aged over 65 years). These people are highly prone to develop inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, irritable bowel syndrome, etc. Inflammatory bowel diseases in geriatric population are very common. This is due to less regenerative capacity of intestinal stem cells and less production of gastric juice in elderly people. Increasing incidences of gastrointestinal disorders in women in Europe and Middle East & Africa is also a major driving factor of EMEA gastrointestinal testing panels market.
Advancement in healthcare and pharmaceutical industries, increasing healthcare expenditure, and rising geriatric population in EMEA are factors expected to drive the demand for gastrointestinal testing panels during the forecast period. Favorable reimbursement policies in the healthcare industry support market growth. Rising prevalence of gastrointestinal complications and digestive disorders demands for gastrointestinal testing panels on a regular basis. Manufacturers operating in the gastrointestinal testing panels market are increasing the production of these devices to fulfill the demand from the healthcare industry. In order to increase the overall well-being of people, market players are introducing innovative products to cater the increasing demand from hospitals, diagnostic laboratories, etc.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 51 Mn |
|
Market Forecast Value in 2031 |
US$ 83.8 Mn |
|
Growth Rate (CAGR) |
4.7% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, supply chain analysis, and parent industry overview. |
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Europe and Middle East & Africa Gastrointestinal Testing Panels Market – Segmentation
TMR’s research study assesses the gastrointestinal testing panels market in EMEA based on pathogen type, type, end-user, and region. The report presents extensive market dynamics and progressive trends associated with different segments and how they influence growth prospects of the gastrointestinal testing panels market in EMEA.
| Pathogen Type |
|
| Type |
|
| End-user |
|
| Region |
|
Europe and Middle East & Africa gastrointestinal testing panels market is expected to reach the value of US$ 83.8 Mn by the end of 2031
Europe and middle East & Africa gastrointestinal testing panels market is estimated to expand at a CAGR of 4.7% from 2021 to 2031
Gastrointestinal testing panels market is driven by increasing healthcare expenditure, rising geriatric population in EMEA and Advancement in healthcare and pharmaceutical industries
The end-use segments in gastrointestinal testing panels market are hospitals and diagnostic laboratories
Key players operating in the gastrointestinal testing panels market in Europe and Middle East & Africa are Becton, Dickinson and Company (BD), vbioMérieux SA, DiaSorin S.p.A (Luminex), Quidel Corporation, QIAGEN, Seegene, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Europe and Middle East & Africa Gastrointestinal Testing Panels Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Gastrointestinal Disorders: Overview
5.2. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by Pathogen Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Pathogen Type, 2017–2031
6.3.1. Viruses
6.3.2. Bacteria
6.3.3. Parasites
7. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Type, 2017–2031
7.3.1. Syndromic Full Multiplex Panel
7.3.2. Low Plex Panel
7.4. Market Attractiveness Analysis, by Type
8. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Point-of-Care
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. Europe
9.2.2. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. Europe Gastrointestinal Testing Panels Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Pathogen Type, 2017–2031
10.2.1. Viruses
10.2.2. Bacteria
10.2.3. Parasites
10.3. Market Value Forecast, by Type, 2017–2031
10.3.1. Syndromic Full Multiplex Panel
10.3.2. Low Plex Panel
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Point-of-Care
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. Germany
10.5.1.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.1.1.1. Viruses
10.5.1.1.2. Bacteria
10.5.1.1.3. Parasites
10.5.1.2. Market Value Forecast, by Type, 2017–2031
10.5.1.2.1. Syndromic Full Multiplex Panel
10.5.1.2.2. Low Plex Panel
10.5.1.3. Market Value Forecast, by End-user, 2017–2031
10.5.1.3.1. Hospitals
10.5.1.3.2. Diagnostic Laboratories
10.5.1.3.3. Point-of-Care
10.5.1.3.4. Others
10.5.2. U.K.
10.5.2.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.2.1.1. Viruses
10.5.2.1.2. Bacteria
10.5.2.1.3. Parasites
10.5.2.2. Market Value Forecast, by Type, 2017–2031
10.5.2.2.1. Syndromic Full Multiplex Panel
10.5.2.2.2. Low Plex Panel
10.5.2.3. Market Value Forecast, by End-user, 2017–2031
10.5.2.3.1. Hospitals
10.5.2.3.2. Diagnostic Laboratories
10.5.2.3.3. Point-of-Care
10.5.2.3.4. Others
10.5.3. France
10.5.3.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.3.1.1. Viruses
10.5.3.1.2. Bacteria
10.5.3.1.3. Parasites
10.5.3.2. Market Value Forecast, by Type, 2017–2031
10.5.3.2.1. Syndromic Full Multiplex Panel
10.5.3.2.2. Low Plex Panel
10.5.3.3. Market Value Forecast, by End-user, 2017–2031
10.5.3.3.1. Hospitals
10.5.3.3.2. Diagnostic Laboratories
10.5.3.3.3. Point-of-Care
10.5.3.3.4. Others
10.5.4. Italy
10.5.4.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.4.1.1. Viruses
10.5.4.1.2. Bacteria
10.5.4.1.3. Parasites
10.5.4.2. Market Value Forecast, by Type, 2017–2031
10.5.4.2.1. Syndromic Full Multiplex Panel
10.5.4.2.2. Low Plex Panel
10.5.4.3. Market Value Forecast, by End-user, 2017–2031
10.5.4.3.1. Hospitals
10.5.4.3.2. Diagnostic Laboratories
10.5.4.3.3. Point-of-Care
10.5.4.3.4. Others
10.5.5. Spain
10.5.5.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.5.1.1. Viruses
10.5.5.1.2. Bacteria
10.5.5.1.3. Parasites
10.5.5.2. Market Value Forecast, by Type, 2017–2031
10.5.5.2.1. Syndromic Full Multiplex Panel
10.5.5.2.2. Low Plex Panel
10.5.5.3. Market Value Forecast, by End-user, 2017–2031
10.5.5.3.1. Hospitals
10.5.5.3.2. Diagnostic Laboratories
10.5.5.3.3. Point-of-Care
10.5.5.3.4. Others
10.5.6. Benelux
10.5.6.1.1. Viruses
10.5.6.1.2. Bacteria
10.5.6.1.3. Parasites
10.5.6.2. Market Value Forecast, by Type, 2017–2031
10.5.6.2.1. Syndromic Full Multiplex Panel
10.5.6.2.2. Low Plex Panel
10.5.6.3. Market Value Forecast, by End-user, 2017–2031
10.5.6.3.1. Hospitals
10.5.6.3.2. Diagnostic Laboratories
10.5.6.3.3. Point-of-Care
10.5.6.3.4. Others
10.5.7. Poland
10.5.7.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.7.1.1. Viruses
10.5.7.1.2. Bacteria
10.5.7.1.3. Parasites
10.5.7.2. Market Value Forecast, by Type, 2017–2031
10.5.7.2.1. Syndromic Full Multiplex Panel
10.5.7.2.2. Low Plex panel
10.5.7.3. Market Value Forecast, by End-user, 2017–2031
10.5.7.3.1. Hospitals
10.5.7.3.2. Diagnostic Laboratories
10.5.7.3.3. Point-of-Care
10.5.7.3.4. Others
10.5.8. Norway
10.5.8.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.8.1.1. Viruses
10.5.8.1.2. Bacteria
10.5.8.1.3. Parasites
10.5.8.2. Market Value Forecast, by Type, 2017–2031
10.5.8.2.1. Syndromic Full Multiplex Panel
10.5.8.2.2. Low Plex Panel
10.5.8.3. Market Value Forecast, by End-user, 2017–2031
10.5.8.3.1. Hospitals
10.5.8.3.2. Diagnostic Laboratories
10.5.8.3.3. Point-of-Care
10.5.8.3.4. Others
10.5.9. Sweden
10.5.9.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.9.1.1. Viruses
10.5.9.1.2. Bacteria
10.5.9.1.3. Parasites
10.5.9.2. Market Value Forecast, by Type, 2017–2031
10.5.9.2.1. Syndromic Full Multiplex Panel
10.5.9.2.2. Low Plex Panel
10.5.9.3. Market Value Forecast, by End-user, 2017–2031
10.5.9.3.1. Hospitals
10.5.9.3.2. Diagnostic Laboratories
10.5.9.3.3. Point-of-Care
10.5.9.3.4. Others
10.5.10. Denmark
10.5.10.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.10.1.1. Viruses
10.5.10.1.2. Bacteria
10.5.10.1.3. Parasites
10.5.10.2. Market Value Forecast, by Type, 2017–2031
10.5.10.2.1. Syndromic Full Multiplex Panel
10.5.10.2.2. Low Plex Panel
10.5.10.3. Market Value Forecast, by End-user, 2017–2031
10.5.10.3.1. Hospitals
10.5.10.3.2. Diagnostic Laboratories
10.5.10.3.3. Point-of-Care
10.5.10.3.4. Others
10.5.11. Finland
10.5.11.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.11.1.1. Viruses
10.5.11.1.2. Bacteria
10.5.11.1.3. Parasites
10.5.11.2. Market Value Forecast, by Type, 2017–2031
10.5.11.2.1. Syndromic Full Multiplex Panel
10.5.11.2.2. Low Plex Panel
10.5.11.3. Market Value Forecast, by End-user, 2017–2031
10.5.11.3.1. Hospitals
10.5.11.3.2. Diagnostic Laboratories
10.5.11.3.3. Point-of-Care
10.5.11.3.4. Others
10.5.12. Austria
10.5.12.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.12.1.1. Viruses
10.5.12.1.2. Bacteria
10.5.12.1.3. Parasites
10.5.12.2. Market Value Forecast, by Type, 2017–2031
10.5.12.2.1. Syndromic Full Multiplex Panel
10.5.12.2.2. Low Plex Panel
10.5.12.3. Market Value Forecast, by End-user, 2017–2031
10.5.12.3.1. Hospitals
10.5.12.3.2. Diagnostic Laboratories
10.5.12.3.3. Point-of-Care
10.5.12.3.4. Others
10.5.13. Switzerland
10.5.13.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.13.1.1. Viruses
10.5.13.1.2. Bacteria
10.5.13.1.3. Parasites
10.5.13.2. Market Value Forecast, by Type, 2017–2031
10.5.13.2.1. Syndromic Full Multiplex Panel
10.5.13.2.2. Low Plex Panel
10.5.13.3. Market Value Forecast, by End-user, 2017–2031
10.5.13.3.1. Hospitals
10.5.13.3.2. Diagnostic Laboratories
10.5.13.3.3. Point-of-Care
10.5.13.3.4. Others
10.5.14. Rest of Europe
10.5.14.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.14.1.1. Viruses
10.5.14.1.2. Bacteria
10.5.14.1.3. Parasites
10.5.14.2. Market Value Forecast, by Type, 2017–2031
10.5.14.2.1. Syndromic Full Multiplex Panel
10.5.14.2.2. Low Plex Panel
10.5.14.3. Market Value Forecast, by End-user, 2017–2031
10.5.14.3.1. Hospitals
10.5.14.3.2. Diagnostic Laboratories
10.5.14.3.3. Point-of-Care
10.5.14.3.4. Others
10.6. Market Attractiveness Analysis
10.6.1. By Pathogen Type
10.6.2. By Type
10.6.3. By End-user
10.6.4. By Country
11. Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Pathogen Type, 2017–2031
11.2.1. Viruses
11.2.2. Bacteria
11.2.3. Parasites
11.3. Market Value Forecast, by Type, 2017–2031
11.3.1. Syndromic Full Multiplex Panel
11.3.2. Low Plex Panel
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Point-of-Care
11.4.4. Others
11.5. Market Value Forecast, by Country, 2017–2031
11.5.1. GCC Countries
11.5.1.1. Market Value Forecast, by Pathogen Type, 2017–2031
11.5.1.1.1. Viruses
11.5.1.1.2. Bacteria
11.5.1.1.3. Parasites
11.5.1.2. Market Value Forecast, by Type, 2017–2031
11.5.1.2.1. Syndromic Full Multiplex Panel
11.5.1.2.2. Low Plex Panel
11.5.1.3. Market Value Forecast, by End-user, 2017–2031
11.5.1.3.1. Hospitals
11.5.1.3.2. Diagnostic Laboratories
11.5.1.3.3. Point-of-Care
11.5.1.3.4. Others
11.5.2. South Africa
11.5.2.1. Market Value Forecast, by Pathogen Type, 2017–2031
11.5.2.1.1. Viruses
11.5.2.1.2. Bacteria
11.5.2.1.3. Parasites
11.5.2.2. Market Value Forecast, by Type, 2017–2031
11.5.2.2.1. Syndromic Full Multiplex Panel
11.5.2.2.2. Low Plex Panel
11.5.2.3. Market Value Forecast, by End-user, 2017–2031
11.5.2.3.1. Hospitals
11.5.2.3.2. Diagnostic Laboratories
11.5.2.3.3. Point-of-Care
11.5.2.3.4. Others
11.5.3. Rest of Middle East & Africa
11.5.3.1. Market Value Forecast, by Pathogen Type, 2017–2031
11.5.3.1.1. Viruses
11.5.3.1.2. Bacteria
11.5.3.1.3. Parasites
11.5.3.2. Market Value Forecast, by Type, 2017–2031
11.5.3.2.1. Syndromic Full Multiplex Panel
11.5.3.2.2. Low Plex Panel
11.5.3.3. Market Value Forecast, by End-user, 2017–2031
11.5.3.3.1. Hospitals
11.5.3.3.2. Diagnostic Laboratories
11.5.3.3.3. Point-of-Care
11.5.3.3.4. Others
11.6. Market Attractiveness Analysis
11.6.1. By Pathogen Type
11.6.2. By Type
11.6.3. By End-user
11.6.4. By Country
12. Competition Landscape
12.1. Company Profiles
12.1.1. Becton, Dickinson and Company (BD)
12.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.1.2. Product Portfolio
12.1.1.3. SWOT Analysis
12.1.1.4. Strategic Overview
12.1.2. bioMérieux SA
12.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.2.2. Product Portfolio
12.1.2.3. SWOT Analysis
12.1.2.4. Strategic Overview
12.1.3. DiaSorin S.p.A (Luminex)
12.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.3.2. Product Portfolio
12.1.3.3. SWOT Analysis
12.1.3.4. Strategic Overview
12.1.4. Quidel Corporation
12.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.4.2. Product Portfolio
12.1.4.3. SWOT Analysis
12.1.4.4. Strategic Overview
12.1.5. QIAGEN
12.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.5.2. Product Portfolio
12.1.5.3. SWOT Analysis
12.1.5.4. Strategic Overview
12.1.6. Seegene, Inc.
12.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.6.2. Product Portfolio
12.1.6.3. SWOT Analysis
12.1.6.4. Strategic Overview
12.1.7. Savyon Diagnostics
12.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.7.2. Product Portfolio
12.1.7.3. SWOT Analysis
12.1.7.4. Strategic Overview
12.1.8. CerTest Biotech S.L.
12.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.8.2. Product Portfolio
12.1.8.3. SWOT Analysis
12.1.8.4. Strategic Overview
12.1.9. Anatolia Geneworks
12.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.9.2. Product Portfolio
12.1.9.3. SWOT Analysis
12.1.9.4. Strategic Overview
List of Tables
Table 01: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031
Table 02: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 03: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 06: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031
Table 07: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 08: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Germany Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031
Table 10: Germany Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 11: Germany Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: U.K. Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031
Table 13: U.K. Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 14: U.K. Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 15: France Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031
Table 16: France Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 17: France Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 18: Italy Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031
Table 19: Italy Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 20: Italy Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Spain Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031
Table 22: Spain Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 23: Spain Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 24: Benelux Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031
Table 25: Benelux Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 26: Benelux Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 27: Poland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031
Table 28: Poland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 29: Poland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 30: Norway Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031
Table 31: Norway Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 32: Norway Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 33: Sweden Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031
Table 34: Sweden Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 35: Sweden Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 36: Denmark Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031
Table 37: Denmark Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 38: Denmark Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 39: Finland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031
Table 40: Finland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 41: Finland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 42: Austria Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031
Table 43: Austria Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 44: Austria Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 45: Switzerland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031
Table 46: Switzerland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 47: Switzerland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 48: Rest of Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031
Table 49: Rest of Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 50: Rest of Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 51: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 52: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031
Table 53: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 54: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 55: GCC Countries Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031
Table 56: GCC Countries Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 57: GCC Countries Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 58: South Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031
Table 59: South Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 60: South Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 61: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031
Table 62: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 63: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by Type, 2020
Figure 03: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by Region, 2020
Figure 04: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by Pathogen Type, 2020
Figure 05: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by End-user, 2020
Figure 06: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 07: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 08: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Viruses, 2017–2031
Figure 09: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Bacteria, 2017–2031
Figure 10: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Parasites, 2017–2031
Figure 11: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 12: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 13: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Syndromic Full Multiplex Panel, 2017–2031
Figure 14: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Low Plex Panel, 2017–2031
Figure 15: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 16: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 17: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Hospitals, 2017–2031
Figure 18: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Diagnostic Laboratories, 2017–2031
Figure 19: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Point-of-Care, 2017–2031
Figure 20: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Others, 2017–2031
Figure 21: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Region, 2020 and 2031
Figure 22: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Region, 2021–2031
Figure 23: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 24: Europe Gastrointestinal Testing Panels Market Value Share, by Country/Sub-region, 2020–2031
Figure 25: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 26: Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 27: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 28: Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 29: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 30: Europe Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 31: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 32: Germany Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 33: Germany Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 34: Germany Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 35: Germany Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 36: Germany Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 37: Germany Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 38: U.K. Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 39: U.K. Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 40: U.K. Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 41: U.K. Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 42: U.K. Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 43: U.K. Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 44: France Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 45: France Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 46: France Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 47: France Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 48: France Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 49: France Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 50: Italy Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 51: Italy Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 52: Italy Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 53: Italy Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 54: Italy Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 55: Italy Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 56: Spain Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 57: Spain Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 58: Spain Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 59: Spain Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 60: Spain Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 61: Spain Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 62: Benelux Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 63: Benelux Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 64: Benelux Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 65: Benelux Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 66: Benelux Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 67: Benelux Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 68: Poland Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 69: Poland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 70: Poland Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 71: Poland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 72: Poland Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 73: Poland Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 74: Norway Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031
Figure 75: Norway Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 76: Norway Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 77: Norway Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 78: Norway Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 79: Norway Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 80: Sweden Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031
Figure 81: Sweden Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 82: Sweden Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 83: Sweden Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 84: Sweden Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 85: Sweden Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 86: Denmark Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031
Figure 87: Denmark Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 88: Denmark Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 89: Denmark Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 90: Denmark Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 91: Denmark Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 92: Finland Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031
Figure 93: Finland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 94: Finland Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 95: Finland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 96: Finland Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 97: Finland Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 98: Austria Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 99: Austria Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 100: Austria Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 101: Austria Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 102: Austria Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 103: Austria Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 104: Switzerland Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031
Figure 105: Switzerland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 106: Switzerland Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 107: Switzerland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 108: Switzerland Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 109: Switzerland Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 110: Rest of Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 111: Rest of Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 112: Rest of Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 113: Rest of Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 114: Rest of Europe Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 115: Rest of Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 116: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 117: Middle East & Africa Gastrointestinal Panel Testing Market Value Share, by Country/Sub-region, 2020–2031
Figure 118: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 119: Middle East & Africa Gastrointestinal Panel Testing Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 120: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 121: Middle East & Africa Gastrointestinal Panel Testing Market Value Share Analysis, by Type, 2020 and 2031
Figure 122: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by Type, 2021–2031
Figure 123: Middle East & Africa Gastrointestinal Panel Testing Market Value Share Analysis, by End-user, 2020 and 2031
Figure 124: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by End-user, 2021–2031
Figure 125: GCC Countries Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031
Figure 126: GCC Countries Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 127: GCC Countries Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 128: GCC Countries Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 129: GCC Countries Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 130: GCC Countries Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 131: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031
Figure 132: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 134: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 135: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 136: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 137: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Figure 138: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031
Figure 139: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031
Figure 140: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031
Figure 141: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031
Figure 142: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031
Figure 143: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Gastrointestinal Testing Panels Market
